BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28161066)

  • 1. Genomic profile in gestational and non-gestational choriocarcinomas.
    Mello JB; Ramos Cirilo PD; Michelin OC; Custódio Domingues MA; Cunha Rudge MV; Rogatto SR; Maestá I
    Placenta; 2017 Feb; 50():8-15. PubMed ID: 28161066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Choriocarcinoma in Women: Analysis of a Case Series With Genotyping.
    Savage J; Adams E; Veras E; Murphy KM; Ronnett BM
    Am J Surg Pathol; 2017 Dec; 41(12):1593-1606. PubMed ID: 28877059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence In Situ Hybridization for the X and Y Chromosome Centromeres Helps Differentiate Between Gestational and Nongestational Choriocarcinoma in Clinically Ambiguous Cases.
    Whaley RD; Dougherty RE; Cheng L; Ulbright TM
    Arch Pathol Lab Med; 2020 Jul; 144(7):863-868. PubMed ID: 31846368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetic genesis of choriocarcinoma].
    Zhao J; Xiang Y; Wan XR; Feng FZ; Cui QC; Yang XY
    Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):35-40. PubMed ID: 20367924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using short tandem repeat analysis for choriocarcinoma diagnosis: a case series.
    Zhang X; Yan K; Chen J; Xie X
    Diagn Pathol; 2019 Aug; 14(1):93. PubMed ID: 31421690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of non-maternal components of gestational choriocarcinoma by PCR-based microsatellite DNA assay.
    Cankovic M; Gaba AR; Meier F; Kim W; Zarbo RJ
    Gynecol Oncol; 2006 Nov; 103(2):614-7. PubMed ID: 16740299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetic analyses of choriocarcinoma.
    Zhao J; Xiang Y; Wan XR; Feng FZ; Cui QC; Yang XY
    Placenta; 2009 Sep; 30(9):816-20. PubMed ID: 19647314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct genomic profiles of gestational choriocarcinoma, a unique cancer of pregnant tissues.
    Jung SH; Choi YJ; Kim MS; Park HC; Han MR; Hur SY; Lee AW; Shin OR; Kim J; Lee SH; Hong D; Song SY; Chung YJ; Lee SH
    Exp Mol Med; 2020 Dec; 52(12):2046-2054. PubMed ID: 33319857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of short tandem repeat analysis in unusual presentations of trophoblastic tumors and their mimics.
    Aranake-Chrisinger J; Huettner PC; Hagemann AR; Pfeifer JD
    Hum Pathol; 2016 Jun; 52():92-100. PubMed ID: 26980014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell proliferative activity and mutation of P53 suppressor gene in human gestational trophoblastic disease.
    Persaud V; Ganjei P; Nadji M
    West Indian Med J; 1993 Dec; 42(4):142-3. PubMed ID: 7909185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p57(KIP2) immunohistochemical staining of gestational trophoblastic tumours does not identify the type of the causative pregnancy.
    Sebire NJ; Rees HC; Peston D; Seckl MJ; Newlands ES; Fisher RA
    Histopathology; 2004 Aug; 45(2):135-41. PubMed ID: 15279631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of human chorionic gonadotropin/human luteinizing hormone receptors in human gestational trophoblastic neoplasms.
    Lei ZM; Rao CV; Ackerman DM; Day TG
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1236-41. PubMed ID: 1592864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic aspects of gestational trophoblastic diseases: a general overview with emphasis on new approaches in determining genetic composition.
    Lage JM; Sheikh SS
    Gen Diagn Pathol; 1997 Nov; 143(2-3):109-15. PubMed ID: 9443568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary intraplacental gestational choriocarcinoma: histologic and genetic analyses.
    Kanehira K; Starostik P; Kasznica J; Khoury T
    Int J Gynecol Pathol; 2013 Jan; 32(1):71-5. PubMed ID: 23202784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexistence of a choriocarcinoma and a gonadoblastoma in the gonad of a 46,XY female: a single nucleotide polymorphism array analysis.
    Beaulieu Bergeron M; Soglio DB; Maietta A; Fournet JC; Blumenkrantz M; Brochu P; Lemieux N
    Pediatr Dev Pathol; 2010; 13(1):66-71. PubMed ID: 19425818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genetics of gestational trophoblastic disease: a rare complication of pregnancy.
    Hoffner L; Surti U
    Cancer Genet; 2012 Mar; 205(3):63-77. PubMed ID: 22469506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative genomic hybridization studies in hydatidiform moles and choriocarcinoma: amplification of 7q21-q31 and loss of 8p12-p21 in choriocarcinoma.
    Ahmed MN; Kim K; Haddad B; Berchuck A; Qumsiyeh MB
    Cancer Genet Cytogenet; 2000 Jan; 116(1):10-5. PubMed ID: 10616525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P63 expression in hydropic abortion and gestational trophoblastic diseases.
    Ramalho LN; Maggiori MS; Ribeiro-Silva A; Peres LC
    Placenta; 2006; 27(6-7):740-3. PubMed ID: 16026831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor.
    Tuncer ZS; Vegh GL; Fulop V; Genest DR; Mok SC; Berkowitz RS
    Gynecol Oncol; 2000 Jun; 77(3):389-93. PubMed ID: 10831347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of maspin in gestational trophoblastic disease.
    Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
    Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.